Opinions
Jim Cramer - Mad Money
Immonumedics
IMMU-Q
COMMENT
Sep 14, 2020
$83.650
Stock price when the opinion was issued
Pharma & Healthcare
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
Advertising
Just four years, this traded at $2, and over $8 last April. It's had 3 CEOs in 18 months, but it was a viable cancer franchise that could be a huge business in a couple years. Gilead announced it was buying it today for $88. Immunomedics shot up nearly 98%.